Clinical trial
SCOTROC 4: A Prospective, Multicentre, Randomised Trial Of Carboplatin Flat Dosing Vs Intrapatient Dose Escalation In First Line Chemotherapy Of Ovarian, Fallopian Tube And Primary Peritoneal Cancers
NCT00098878 is registered in ClinicalTrials.gov with NHS Greater Glasgow and Clyde as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SCOTROC 4: A Prospective, Multicentre, Randomised Trial Of Carboplatin Flat Dosing Vs Intrapatient Dose Escalation In First Line Chemotherapy Of Ovarian, Fallopian Tube And Primary Peritoneal Cancers
- Lead sponsor
- NHS Greater Glasgow and Clyde
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2004
- Completion date
- July 31, 2010
- Enrollment
- 1,300 (estimated)
- Sites
- 88
Conditions
As the registry lists them; a condition with its own page is linked.
fallopian tube cancer, ovarian cancer, primary peritoneal cavity cancer